比较两种血压目标对院外心脏骤停后全脑代谢影响的随机双盲试验
该研究为BOX试验的子研究,将60例院外心脏骤停后昏迷患者随机分入低MAP(63 mmHg)或高MAP(77 mmHg)组,持续96小时监测颈静脉球微透析与脑氧饱和度。两组MAP明确分离(15 mmHg,p<0.001),但脑生化变量无显著差异(乳酸/丙酮酸比值低MAP组19(16-31) vs 高MAP组23(16-33),p=0.64),两组前30小时乳酸/丙酮酸比值均持续>16。前24小时脑乳酸>2.5 mM、丙酮酸>110 µM、乳酸/丙酮酸比值>30、甘油>260 µM对不良神经预后和死亡有高度预测价值(AUC 0.80)。作者认为,ROSC后最初数小时组织氧合与再循环不足可能是决定神经预后的关键因素。
要点
- 60例OHCA后昏迷患者随机分为低MAP(63 mmHg)与高MAP(77 mmHg)组,ROSC后180分钟开始目标血压管理。
- 两组MAP明确分离15 mmHg(p<0.001),但脑乳酸/丙酮酸比值无显著差异:低MAP组19(16-31) vs 高MAP组23(16-33),p=0.64。
- 两组前30小时脑乳酸/丙酮酸比值均持续>16,提示再复苏阶段脑氧化还原状态持续异常。
- 前24小时脑乳酸>2.5 mM、丙酮酸>110 µM、乳酸/丙酮酸比值>30、甘油>260 µM对不良神经预后和死亡有高度预测价值,AUC 0.80。
- 前48小时脑氧饱和度中位数低MAP组69.5%(62.0-75.0%) vs 高MAP组69.0%(61.3-75.5%),p=0.16。
适用人群与场景
- 院外心脏骤停(OHCA)后复苏成功、仍处于昏迷状态的患者,纳入本随机双盲试验。
- 研究场景为复苏后重症监护阶段,ROSC后180分钟开始按目标血压管理。
诊断标准与关键阈值
- 脑乳酸/丙酮酸比值(LPR)作为细胞氧化还原状态标志物,缺血、缺氧或线粒体功能障碍时升高。
- 前24小时脑乳酸>2.5 mM、丙酮酸>110 µM、乳酸/丙酮酸比值>30、甘油>260 µM对不良神经预后和死亡有高度预测价值(AUC 0.80)。
处置流程与药物剂量
- ROSC后180分钟起,低MAP组目标平均动脉压63 mmHg,高MAP组目标平均动脉压77 mmHg。
- 持续96小时监测颈静脉球微透析(JBM)与脑氧饱和度(rSO2)。
红旗征与不能漏的情况
- 前24小时脑乳酸>2.5 mM、丙酮酸>110 µM、乳酸/丙酮酸比值>30、甘油>260 µM提示不良神经预后和死亡风险高(AUC 0.80)。
- 两组前30小时乳酸/丙酮酸比值均持续>16,提示再复苏阶段脑氧化还原状态持续异常。
研究设计与关键结果
- 研究类型:随机双盲试验,为BOX试验(院外心脏骤停后血压与氧合目标试验)的子研究;样本量60例昏迷患者。
- 干预与对照:低MAP组(目标63 mmHg) vs 高MAP组(目标77 mmHg),ROSC后180分钟开始。
- 主要终点:两组脑能量代谢物时间平均均值无显著差异,乳酸/丙酮酸比值低MAP组19(16-31) vs 高MAP组23(16-33),p=0.64。
- 两组MAP明确分离15 mmHg,p<0.001。
- 两组前30小时乳酸/丙酮酸比值均持续>16。
- 前24小时脑乳酸>2.5 mM、丙酮酸>110 µM、乳酸/丙酮酸比值>30、甘油>260 µM对不良神经预后和死亡高度预测,AUC 0.80。
- 前48小时rSO2中位数低MAP组69.5%(62.0-75.0%) vs 高MAP组69.0%(61.3-75.5%),p=0.16。
- 不良临床结局患者表现出显著更差的生化模式。
证据类型、等级与局限
- 证据类型:随机双盲试验(BOX试验子研究)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于OHCA后昏迷患者,ROSC后180分钟起以较高MAP(77 mmHg)为目标未显著改善96小时内脑能量代谢,不支持仅以改善脑代谢为目的常规采用较高MAP目标。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: This study aimed to assess the effect of different blood pressure levels on global cerebral metabolism in comatose patients resuscitated from out-of-hospital cardiac arrest (OHCA).
METHODS: In a double-blinded trial, we randomly assigned 60 comatose patients following OHCA to low (63 mmHg) or high (77 mmHg) mean arterial blood pressure (MAP). The trial was a sub-study in the Blood Pressure and Oxygenation Targets after Out-of-Hospital Cardiac Arrest-trial (BOX). Global cerebral metabolism utilizing jugular bulb microdialysis (JBM) and cerebral oxygenation (rSO2) was monitored continuously for 96 h. The lactate-to-pyruvate (LP) ratio is a marker of cellular redox status and increases during deficient oxygen delivery (ischemia, hypoxia) and mitochondrial dysfunction. The primary outcome was to compare time-averaged means of cerebral energy metabolites between MAP groups during post-resuscitation care. Secondary outcomes included metabolic patterns of cerebral ischemia, rSO2, plasma neuron-specific enolase level at 48 h and neurological outcome at hospital discharge (cerebral performance category).
RESULTS: We found a clear separation in MAP between the groups (15 mmHg, p < 0.001). Cerebral biochemical variables were not significantly different between MAP groups (LPR low MAP 19 (16-31) vs. high MAP 23 (16-33), p = 0.64). However, the LP ratio remained high (> 16) in both groups during the first 30 h. During the first 24 h, cerebral lactate > 2.5 mM, pyruvate levels > 110 µM, LP ratio > 30, and glycerol > 260 µM were highly predictive for poor neurological outcome and death with AUC 0.80. The median (IQR) rSO2 during the first 48 h was 69.5% (62.0-75.0%) in the low MAP group and 69.0% (61.3-75.5%) in the high MAP group, p = 0.16.
CONCLUSIONS: Among comatose patients resuscitated from OHCA, targeting a higher MAP 180 min after ROSC did not significantly improve cerebral energy metabolism within 96 h of post-resuscitation care. Patients with a poor clinical outcome exhibited significantly worse biochemical patterns, probably illustrating that insufficient tissue oxygenation and recirculation during the initial hours after ROSC were essential factors determining neurological outcome.
参考来源
- Mølstrøm S, Nielsen TH, Nordstrøm CH, et al. A randomized, double-blind trial comparing the effect of two blood pressure targets on global brain metabolism after out-of-hospital cardiac arrest. Crit Care. 2023. PMID: 36823636. doi:10.1186/s13054-023-04376-y
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。